vs
Progyny, Inc.（PGNY）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
Progyny, Inc.的季度营收约是ROGERS CORP的1.6倍（$318.4M vs $200.5M），Progyny, Inc.净利率更高（3.9% vs 2.2%，领先1.7%），Progyny, Inc.同比增速更快（6.7% vs 5.2%），Progyny, Inc.自由现金流更多（$48.6M vs $1.1M），过去两年Progyny, Inc.的营收复合增速更高（7.0% vs -3.3%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
PGNY vs ROG — 直观对比
营收规模更大
PGNY
是对方的1.6倍
$200.5M
营收增速更快
PGNY
高出1.4%
5.2%
净利率更高
PGNY
高出1.7%
2.2%
自由现金流更多
PGNY
多$47.5M
$1.1M
两年增速更快
PGNY
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $200.5M |
| 净利润 | $12.5M | $4.5M |
| 毛利率 | 24.1% | 32.2% |
| 营业利润率 | 4.8% | — |
| 净利率 | 3.9% | 2.2% |
| 营收同比 | 6.7% | 5.2% |
| 净利润同比 | 18.5% | 421.4% |
| 每股收益（稀释后） | $0.14 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $318.4M | $201.5M | ||
| Q3 25 | $313.3M | $216.0M | ||
| Q2 25 | $332.9M | $202.8M | ||
| Q1 25 | $324.0M | $190.5M | ||
| Q4 24 | $298.4M | $192.2M | ||
| Q3 24 | $286.6M | $210.3M | ||
| Q2 24 | $304.1M | $214.2M |
净利润PGNYROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $12.5M | $4.6M | ||
| Q3 25 | $13.9M | $8.6M | ||
| Q2 25 | $17.1M | $-73.6M | ||
| Q1 25 | $15.1M | $-1.4M | ||
| Q4 24 | $10.5M | $-500.0K | ||
| Q3 24 | $10.4M | $10.7M | ||
| Q2 24 | $16.5M | $8.1M |
毛利率PGNYROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 24.1% | 31.5% | ||
| Q3 25 | 23.2% | 33.5% | ||
| Q2 25 | 23.7% | 31.6% | ||
| Q1 25 | 23.4% | 29.9% | ||
| Q4 24 | 21.3% | 32.1% | ||
| Q3 24 | 20.7% | 35.2% | ||
| Q2 24 | 22.5% | 34.1% |
营业利润率PGNYROG
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | 3.5% | ||
| Q3 25 | 6.9% | 7.3% | ||
| Q2 25 | 7.3% | -33.3% | ||
| Q1 25 | 7.5% | -0.2% | ||
| Q4 24 | 5.3% | -6.6% | ||
| Q3 24 | 4.3% | 6.9% | ||
| Q2 24 | 6.8% | 5.3% |
净利率PGNYROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 3.9% | 2.3% | ||
| Q3 25 | 4.4% | 4.0% | ||
| Q2 25 | 5.1% | -36.3% | ||
| Q1 25 | 4.6% | -0.7% | ||
| Q4 24 | 3.5% | -0.3% | ||
| Q3 24 | 3.6% | 5.1% | ||
| Q2 24 | 5.4% | 3.8% |
每股收益（稀释后）PGNYROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.14 | $0.20 | ||
| Q3 25 | $0.15 | $0.48 | ||
| Q2 25 | $0.19 | $-4.00 | ||
| Q1 25 | $0.17 | $-0.08 | ||
| Q4 24 | $0.12 | $-0.04 | ||
| Q3 24 | $0.11 | $0.58 | ||
| Q2 24 | $0.17 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $516.0M | $1.2B |
| 总资产 | $742.4M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PGNYROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $112.2M | $197.0M | ||
| Q3 25 | $134.0M | $167.8M | ||
| Q2 25 | $132.5M | $157.2M | ||
| Q1 25 | $109.2M | $175.6M | ||
| Q4 24 | $162.3M | $159.8M | ||
| Q3 24 | $91.5M | $146.4M | ||
| Q2 24 | $95.0M | $119.9M |
股东权益PGNYROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $516.0M | $1.2B | ||
| Q3 25 | $560.0M | $1.2B | ||
| Q2 25 | $515.0M | $1.2B | ||
| Q1 25 | $467.2M | $1.3B | ||
| Q4 24 | $422.1M | $1.3B | ||
| Q3 24 | $434.9M | $1.3B | ||
| Q2 24 | $456.2M | $1.3B |
总资产PGNYROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $742.4M | $1.4B | ||
| Q3 25 | $795.2M | $1.4B | ||
| Q2 25 | $761.0M | $1.5B | ||
| Q1 25 | $730.3M | $1.5B | ||
| Q4 24 | $607.1M | $1.5B | ||
| Q3 24 | $660.0M | $1.5B | ||
| Q2 24 | $698.6M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $1.1M |
| 自由现金流率自由现金流/营收 | 15.3% | 0.5% |
| 资本支出强度资本支出/营收 | 1.8% | 2.3% |
| 现金转化率经营现金流/净利润 | 4.34× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $191.8M | $70.1M |
8季度趋势，按日历期对齐
经营现金流PGNYROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $54.2M | $46.9M | ||
| Q3 25 | $50.7M | $28.9M | ||
| Q2 25 | $55.5M | $13.7M | ||
| Q1 25 | $49.8M | $11.7M | ||
| Q4 24 | $52.2M | $33.7M | ||
| Q3 24 | $44.5M | $42.4M | ||
| Q2 24 | $56.7M | $22.9M |
自由现金流PGNYROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $48.6M | $42.2M | ||
| Q3 25 | $46.0M | $21.2M | ||
| Q2 25 | $50.2M | $5.6M | ||
| Q1 25 | $47.0M | $2.1M | ||
| Q4 24 | $50.3M | $18.3M | ||
| Q3 24 | $42.7M | $25.2M | ||
| Q2 24 | $55.8M | $8.8M |
自由现金流率PGNYROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 15.3% | 20.9% | ||
| Q3 25 | 14.7% | 9.8% | ||
| Q2 25 | 15.1% | 2.8% | ||
| Q1 25 | 14.5% | 1.1% | ||
| Q4 24 | 16.8% | 9.5% | ||
| Q3 24 | 14.9% | 12.0% | ||
| Q2 24 | 18.4% | 4.1% |
资本支出强度PGNYROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 1.8% | 2.3% | ||
| Q3 25 | 1.5% | 3.6% | ||
| Q2 25 | 1.6% | 4.0% | ||
| Q1 25 | 0.9% | 5.0% | ||
| Q4 24 | 0.6% | 8.0% | ||
| Q3 24 | 0.6% | 8.2% | ||
| Q2 24 | 0.3% | 6.6% |
现金转化率PGNYROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 4.34× | 10.20× | ||
| Q3 25 | 3.65× | 3.36× | ||
| Q2 25 | 3.24× | — | ||
| Q1 25 | 3.31× | — | ||
| Q4 24 | 4.95× | — | ||
| Q3 24 | 4.27× | 3.96× | ||
| Q2 24 | 3.44× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
ROG
暂无分部数据
